BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Revealing the Unseen: AI's Role in Novel Target Discovery  for Hig
 h Unmet Needs Areas Through Multi-Omics Integration - Namshik Han\, Head o
 f Computational Research &amp\; AI\, Milner Therapeutics Institute\, Unive
 rsity of Cambridge 
DTSTART:20241021T110000Z
DTEND:20241021T113000Z
UID:TALK222685@talks.cam.ac.uk
CONTACT:124528
DESCRIPTION:The role of AI and data-driven methodologies is set to play a 
 huge part in the drug discovery industry\, allowing intricate details of a
  multitude of disease mechanisms and improving the way for the streamlined
  development of therapeutics. The focus of this seminar would give an over
 view of how AI and Multi-Omics are shaping betterment in the area of the i
 mproved identification and profiling of therapeutic targets.\n\nI will des
 cribe the general AI principles and show how they apply to drug discovery 
 in a manner that can be followed by a wide audience. This should give the 
 participants with even the barest understanding of the technical backgroun
 d an understanding of the value that this tool adds in drug discovery. I s
 hall take our research using AI and machine learning coupled with advanced
  mathematical models. Integrative analysis of multi-omics datasets enabled
  identifying new targets and pathways that may suggest new avenues for the
 ir use in understanding complex biological questions.\n\nThe presentation 
 also focuses on how such academic insights work out in the domain of comme
 rce and further reflected through my experiences of founding and running A
 I-driven Startups: Kure.ai Therapeutics and CardiaTec Biosciences. The sec
 ond one will bring out examples that evidently show the relevance of our f
 indings in practical scenarios of developing innovative solutions in the a
 rea of cardiovascular diseases.\n\nThe talk concludes with a Q&A session a
 nd gives a very succinct but also very full picture of the role of AI and 
 data-driven methods in modern drug discovery. It is in this regard that th
 e subject of the seminar will put forth how these emerging technologies ar
 e enablers for increased precision and efficiency in the development of th
 erapeutics today or will be\, thus allowing an informed discussion among p
 articipants hailing from academia to biotech to big pharmaceuticals.
LOCATION:FW11\, Willam Gates building (Department of Computer Science and 
 Technology)
END:VEVENT
END:VCALENDAR